Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis

*Author for correspondence: Tel.: +43 1 404 002 6150;

E-mail Address: shahrokh.shariat@meduniwien.ac.at

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria

Institute for Urology & Reproductive Health, Sechenov University, Moscow 119991, Russia

Department of Urology, Weill Cornell Medical College, New York, NY 14853, USA

Department of Urology, University of Texas Southwestern, Dallas, TX 75390, USA

Department of Urology, Second Faculty of Medicine, Charles University, Prague 15006, Czech Republic

Karl Landsteiner Institute of Urology & Andrology, Vienna 1010, Austria

Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman 11942, Jordan

留言 (0)

沒有登入
gif